Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New design may lead to custom-tailored drugs with no side effects

18.06.2008
In the May issue of the British journal Drug Discovery Today, Sten Ohlson, professor of biotechnology at Kalmar University in Sweden, argues in a debate article how his thoughts and research results surrounding weak or transient interactions between biochemical molecules could revolutionize tomorrow's drugs.

Sten Ohlson has extensive experience of research into so-called transient biomolecular binding. Such binding is short-lived­-the biomolecules touch each other for a brief moment only. Many of the processes in the human body­-in a cell, for instance­-occur with the aid of transient binding.

The discovery and understanding of how important binding can be is now paving the way for an entirely new type of drug that will be both more effective and multicompetent and moreover will be less likely than today's drugs to lead to the development of tolerance in patients.

It is above all in three areas that Professor Sten Ohlson envisions major potential for the new technology: cardiovascular diseases, pain, and neurological disorders.

... more about:
»Ohlson »Sten »binding

Some multicompetent drugs based on transient interaction are already in use today. One of them is regular aspirin, where acetyl salicylic acid transiently binds to many target structures and thereby works both as a pain reliever and an inflammation alleviator.

At present Sten Ohlson is collaborating with drug companies in the search for substances that can prevent blood clots in connection with heart attacks and stroke.

Sten Ohlson's research on the importance of transient molecular bindings in biological systems is revolutionary, but he maintains that its application is predicated upon other researchers' abandoning old, traditional approaches.

"The greatest obstacle at present, I believe, is getting scientists to begin to think transiently. This is an entirely new way of conceptualizing and understanding the fundamental functions of diseases that affect us and how we can cure them," says Sten Ohlson.

Karin Ekebjär | alfa
Further information:
http://www.hik.se

Further reports about: Ohlson Sten binding

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>